These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7229900)

  • 1. [Study of polymorphous transformations of sulfanilamide during table manufacture (author's transl)].
    Cruaud O; Duchêne D; Puisieux F; Chauvet A; Masse J
    J Pharm Belg; 1981; 36(1):15-20. PubMed ID: 7229900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tablets. IX. Study of the compressibility of a grain of sulfanilamide].
    Duchêne MD; Terrier JL; Paris MJ; Mangeot A; Puisieux F
    Ann Pharm Fr; 1973; 31(7):521-32. PubMed ID: 4793462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of tablets. 10. Influence of non-ionic surfactants on the compressibility of sulfanilamide].
    Duchêne D; Terrier JL; Clerc J; Puisieux F
    Ann Pharm Fr; 1973; 31(9):583-92. PubMed ID: 4793701
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of formation of an hydrophilic and continuous network of starch on tablets properties. II. Repercussion on tablets characteristics, depending on conditions of the compression (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(3):175-82. PubMed ID: 480129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Temperature dependence of the modification of sulfanilamides during tablet compression].
    Kala H; Traue J; Haack U; Moldenhauer H; Kedvessy G; Selmeczi B
    Pharmazie; 1982 Sep; 37(9):674-5. PubMed ID: 7146079
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tablets. VII. Influence of granulation procedure on the properties of sulfanilamide grains and tablets].
    Terrier JL; Duchêne D; Clerc J; Puisieux F
    Ann Pharm Fr; 1972 Dec; 30(12):827-36. PubMed ID: 4668288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tablets. XII. Influence of the nature of certain adjuvants on the qualities of grains and tablets of sulfanilamide. Study of paired diluants: potato starch--tricalcium phosphate].
    Ambandh MY; Paris J; Mangenot O; Puisieux F; Duchene D
    J Pharm Belg; 1974; 29(6):523-38. PubMed ID: 4465437
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tablets. I. Influence of granulometry and the presence of ether bound non-ionic surfactants on the quality of grains and tablets of sulfanilamide].
    Duchêne D; Puisieux F; Le Hir A
    Ann Pharm Fr; 1969 Apr; 27(4):309-22. PubMed ID: 5400254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution to the study on phenylbutazone-sulfamides. I. -- Phenylbutazone-sulfanilamide and phenylbutazone-sulfathiazol associations (author's transl)].
    Jeanjean B; Alberola S; Rambaud J; Sabon F
    Ann Pharm Fr; 1979; 37(5-6):175-80. PubMed ID: 543592
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preparation of solutions for sulfanilamide preparation injections in pharmacy and in pharmaceutical manufacture].
    Voropanov EI
    Farmatsiia; 1976; 25(4):24-8. PubMed ID: 1010046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of tablets. 3. Influence of non-ionic surfactants with ester linkage on qualities of sulfanilamide grains and tablets].
    Duchêne D; Djiane A; Puisieux F
    Ann Pharm Fr; 1970 Apr; 28(4):289-98. PubMed ID: 5430303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ordered mixing (author's transl)].
    Verraes J; Kinget R
    J Pharm Belg; 1979; 34(5):297-307. PubMed ID: 512832
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tablets formulation from standardized citroflavenoids and study of presentation (author's transl)].
    Pourrat A; Renoux R; Jean D
    Ann Pharm Fr; 1978; 36(5-6):253-62. PubMed ID: 707954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Formulation study of phenacetin tablets by direct compression (author's transl)].
    Tshimpangila D; Delattre L
    J Pharm Belg; 1980; 35(5):357-63. PubMed ID: 7452441
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study of release from tablets. A comparison of four methods (author's transl)].
    Fu YK; Xu AX; Bao JX; Li DL; Zhang XF; Xing CY
    Yao Xue Xue Bao; 1980 Jul; 15(7):422-8. PubMed ID: 7424529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the study on the resistance of tablets].
    Motycková S
    Cesk Farm; 1966 Feb; 15(2):94-7. PubMed ID: 5933846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Some typical methods of data treatment in the research of release from tablets (author's transl)].
    Fang JQ
    Yao Xue Xue Bao; 1980 Jul; 15(7):441-8. PubMed ID: 7424533
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG; Law D; Schmitt EA; Qiu Y
    Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various considerations on the industrial manufacture of pharmaceutical tablets].
    DOLIQUE M
    J Pharm Belg; 1960; 15():229-68. PubMed ID: 13723553
    [No Abstract]   [Full Text] [Related]  

  • 20. [Equipments and aqueous coating procedures with low viscosity HPMC at laboratory scale (author's transl)].
    Delporte JP; De Seille JM; Jaminet F
    J Pharm Belg; 1981; 36(5):337-47. PubMed ID: 7310628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.